MicroRNA Expression as Blood Biomarkers for Schizophrenia
Author Information
Author(s): Lai Chi-Yu, Yu Sung-Liang, Hsieh Ming H., Chen Chun-Houh, Chen Hsuan-Yu, Wen Chun-Chiang, Huang Yung-Hsiang, Hsiao Po-Chang, Hsiao Chuhsing Kate, Liu Chih-Min, Yang Pan-Chyr, Hwu Hai-Gwo, Chen Wei J.
Primary Institution: National Taiwan University
Hypothesis
This study aimed to identify potential miRNA signatures for schizophrenia by comparing genome-wide miRNA expression profiles in patients with schizophrenia versus healthy controls.
Conclusion
The study found that a seven-miRNA signature could serve as a feasible way to identify biomarkers for schizophrenia.
Supporting Evidence
- A seven-miRNA signature was derived with an AUC of 93% in the learning set.
- The expression levels of miR-34a were significantly different between cases and controls.
- The study included a total of 90 schizophrenia patients and 60 healthy controls.
Takeaway
Scientists looked at tiny molecules in the blood to find clues about schizophrenia, and they found a special group of seven that might help doctors understand and diagnose the illness better.
Methodology
The study used a Taqman array to profile miRNA expression in mononuclear leukocytes from schizophrenia patients and healthy controls, validating findings in a separate testing set.
Potential Biases
Potential bias due to the influence of medications and educational level differences.
Limitations
The study did not account for the effects of medications on miRNA expression and had differences in educational levels between patients and controls.
Participant Demographics
90 patients with schizophrenia and 60 healthy controls, matched for age and sex.
Statistical Information
P-Value
0.005 for hsa-miR-34a in both learning and testing sets.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website